Brenus Pharma today announced that first patients have been successfully dosed in its first-in-human clinical trial evaluating STC-1010, the company’s lead in vivo immunotherapy candidate developed through its proprietary off-the-shelf platform. Three patients have already been enrolled in the study. The first completed eight weeks of treatment with no adverse events attributed to the investigational therapy. This trial targets patients with unresectable, locally advanced or metastatic colorect...

Power Integrations is rolling out a new reference design kit tailored specifically for solar-powered race cars as 37 student teams prepare to race across the Outback in the Bridgestone World Solar Challenge starting August 24. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250821250611/en/RDK-85SLR includes everything needed to create a 46-watt power supply. Solar race car teams can get the kit free by registering online. The kit, R...